Please use this identifier to cite or link to this item:
|Title:||Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study.||Austin Authors:||Tran, Tim ;Ford, James;Hardidge, Andrew J ;Antoine, Shari;Veevers, Beth;Taylor, Simone E ;Elliott, Rohan A||Affiliation:||Pharmacy
Health Independence Program, Austin Health, Heidelberg, VIC, Australia..
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia..
|Issue Date:||12-Jul-2022||Date:||2022||Publication information:||International Journal of Clinical Pharmacy 2022; 44(6)||Abstract:||More than 70% of patients continue to use opioid medications 3-weeks following total knee arthroplasty. Post-discharge pharmacist reviews improve medication management, however it's effect on opioid usage is not known. This study aimed to evaluate the impact of post-discharge pharmacist review on opioid use following a total knee arthroplasty. A pilot, cohort pre- and post-intervention study was undertaken on patients who had undergone a total knee arthroplasty and were supplied an opioid upon discharge from hospital. During the intervention, patients were contacted via telephone by a pharmacist approximately five days post-discharge to review analgesic usage, provide education and advice and communicate an opioid management plan to their general practitioner. The primary endpoint was the percentage of patients taking opioids 3-weeks post-discharge. Secondary endpoints included: percentage of patients obtaining an opioid refill; patient satisfaction with opioid supply and the pharmacist review. Pre- and post-intervention, 63 and 44 patients were included, respectively. The percentage of patients taking opioids 3-weeks post-discharge declined from 74.6 to 29.6% (p < 0.001) and the percentage requiring an opioid refill from their general practitioner declined from 71.4 to 36.4% (p < 0.001). More patients were satisfied with opioid supply during the intervention period (79.5% cf. 47.6%, p = 0.001). Twenty-eight (63.6%) patients could recall the post-discharge pharmacist review, and all were either satisfied or extremely satisfied with the review. Pharmacist-delivered post-discharge analgesia review reduced the percentage of patients taking opioids 3-weeks post-discharge following a total knee arthroplasty. This intervention has the potential to provide a smoother transition of care for patients supplied with opioids at the time of hospital discharge.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/30554||DOI:||10.1007/s11096-022-01455-y||ORCID:||http://orcid.org/0000-0002-2924-3466
|Journal:||International journal of clinical pharmacy||PubMed URL:||35829822||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35829822/||Type:||Journal Article||Subjects:||Opioids
Transitions of care
|Appears in Collections:||Journal articles|
Show full item record
checked on Sep 27, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.